Veterinary Medicines

Suiseng Suspension for injection for pigs

Not authorised
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F6
  • Escherichia coli, LT toxoid
Download as PDF

Product identification

Medicine name:
Suiseng Suspension for injection for pigs
SUISENG
Active substance:
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F6
  • Escherichia coli, LT toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, fimbrial adhesin F4ac
    78.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F5
    79.00
    percent
    /
    1.00
    Dose
  • Clostridium perfringens, type C, beta toxoid
    35.00
    percent
    /
    1.00
    Dose
  • Clostridium novyi, type B, alpha toxoid
    50.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ab
    65.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F6
    80.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, LT toxoid
    55.00
    percent
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:
  • Cardboard box with 1 PET vial of 125 doses (250 ml). 250 ml PET plastic vials, closed with type I rubber stoppers and aluminium caps.
  • Cardboard box with1 PET vial of 50 doses (100 ml). 100 ml PET plastic vials, closed with type I rubber stoppers and aluminium caps.
  • Cardboard box with 1 glass vial of 25 doses (50 ml). 50 ml Type-I colourless glass vials, closed with type I rubber stoppers and aluminium caps.
  • Cardboard box with 1 glass vial of 10 doses (20 ml).20 ml Type-I colourless glass vials, closed with type I rubber stoppers and aluminium caps.
  • Cardboard box with1 Glass vial of 50 doses (100 ml). 100 ml Type-I colourless glass vials, closed with type I rubber stoppers and aluminium caps.
  • Cardboard box with 1 PET vial of 25 doses (50 ml). , 50 ml PET plastic vials, closed with type I rubber stoppers and aluminium caps
  • Cardboard box with 1 PET vial of 10 doses (20 ml).20 ml PET plastic vials, closed with type I rubber stoppers and aluminium caps.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1284717 6/2009
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0461/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/04/2022
Download